|Company name||Kindred Healthcare, Inc.|
NEW YORK, December 20, 2017 – Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Kindred Healthcare, Inc. (NASDAQ: KND) stockholders concerning the proposed acquisition of the company by TPG Capital, Welsh, Carson, Anderson & Stowe, and Humana Inc. (NYSE: HUM) (collectively, the “consortium”).
Our investigation concerns whether Kindred’s board of directors failed to adequately shop the company and obtain the best possible value for its stockholders before entering into a definitive merger agreement with the consortium. Under the terms of the agreement, each outstanding share of Kindred common stock will be exchanged for $9.00 per share in cash.
If you own Kindred shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato at email@example.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.